Cargando…
Effects of Ezetimibe Added to Ongoing Statin Therapy on C-Reactive Protein Levels in Hypercholesterolemic Patients
BACKGROUND AND OBJECTIVES: Ezetimibe alone does not decrease C-reactive protein (CRP) levels in hypercholesterolemic patients. However, several reports have suggested that ezetimibe might potentiate the effect of statin not only on cholesterol but also on CRP when administered together. We investiga...
Autores principales: | Oh, Min Seok, Min, Yun Joo, Kwon, Jee Eun, Cho, Eun Jeong, Kim, Jung Eun, Lee, Wang-Soo, Lee, Kwang Je, Kim, Sang-Wook, Kim, Tae Ho, Kim, Chee Jeong, Ryu, Wang Seong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116103/ https://www.ncbi.nlm.nih.gov/pubmed/21731566 http://dx.doi.org/10.4070/kcj.2011.41.5.253 |
Ejemplares similares
-
Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014) -
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
por: Yu, Chih-Chieh, et al.
Publicado: (2012) -
The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus
por: Sharifi, Faranak, et al.
Publicado: (2013) -
Acute Viral Myopericarditis Presenting as a Transient Effusive-Constrictive Pericarditis Caused by Coinfection with Coxsackieviruses A4 and B3
por: Lee, Wang-Soo, et al.
Publicado: (2012) -
Effects of the Transition from Premenopause to Postmenopause on Lipids and Lipoproteins: Quantification and Related Parameters
por: Cho, Eun Jeung, et al.
Publicado: (2011)